{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:13:37Z","timestamp":1790781217683,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.canrad.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T04:06:37Z","timestamp":1624507597000},"page":"545-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nouvelles indications de protonth\u00e9rapie et essais cliniques en cours\u00a0: tumeurs intracr\u00e2niennes"],"prefix":"10.1016","volume":"25","author":[{"given":"P.","family":"Lesueur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lecornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Calugaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Florescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Missohou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Geffrelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Feuvret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Balosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.06.009_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2019.08.019","article-title":"Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy","volume":"142","author":"Florijn","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ctrv.2018.11.004","article-title":"Proton therapy for treatment of intracranial benign tumors in adults: a systematic review","volume":"72","author":"Lesueur","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2021.06.009_bib0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","article-title":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042-26042)","volume":"128","author":"Weber","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF01403492","article-title":"The choice of treatment after incomplete adenomectomy in acromegaly: proton- versus highvoltage radiation","volume":"96","author":"L\u00fcdecke","year":"1989","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.canrad.2021.06.009_bib0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijrobp.2005.07.978","article-title":"Fractionated proton beam irradiation of pituitary adenomas","volume":"64","author":"Ronson","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.009_bib0135","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijrobp.2014.06.068","article-title":"Outcomes of proton therapy for patients with functional pituitary adenomas","volume":"90","author":"Wattson","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.009_bib0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3938\/jkps.74.389","article-title":"Dosimetric comparisons of intensity-modulated radiotherapy, volumetric modulated arc therapy, tomotherapy, stereotactic radiosurgery, and proton therapy for treatment of patients with a vestibular schwannoma","volume":"74","author":"Oh","year":"2019","journal-title":"J Korean Phys Soc"},{"key":"10.1016\/j.canrad.2021.06.009_bib0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14338\/IJPT-14-00014.1","article-title":"Fractionated proton beam therapy for acoustic neuromas: tumor control and hearing preservation","volume":"4","author":"Barnes","year":"2018","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.canrad.2021.06.009_bib0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ijrobp.2009.03.076","article-title":"Risks of radiation therapy in patients with neurofibromatosis","volume":"75","author":"Grill","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.009_bib0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11060-020-03432-9","article-title":"Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study","volume":"147","author":"Rutenberg","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijrobp.2010.11.027","article-title":"Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas","volume":"82","author":"Boehling","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.009_bib0165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.14338\/IJPT-14-00023.1","article-title":"Proton and X-ray radiation for head and neck paragangliomas","volume":"1","author":"Ioannides","year":"2015","journal-title":"Int J Particle Ther"},{"key":"10.1016\/j.canrad.2021.06.009_bib0170","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.1016\/j.ijrobp.2016.06.907","article-title":"First report of paragangliomas treated with proton therapy","volume":"96","author":"Chowdhury","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.009_bib0175","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hed.26044","article-title":"Proton therapy for head and neck paragangliomas: a single institutional experience","volume":"42","author":"Kang","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.06.009_bib0180","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1470-2045(21)00154-6","article-title":"Benefit of adjuvant, but not concurrent, temozolomide for IDH-mutant anaplastic astrocytoma","volume":"22","author":"Sasaki","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2020.11.004","article-title":"Proton therapy for selected low grade glioma patients in the Netherlands","volume":"154","author":"van der Weide","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0190","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1016\/j.prro.2019.02.002","article-title":"Patterns of failure among patients with low-grade glioma treated with proton radiation therapy","volume":"9","author":"Kamran","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.04.027","article-title":"Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma","volume":"137","author":"Tabrizi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0200","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.ijrobp.2019.06.132","article-title":"Prospective phase II randomized trial comparing proton therapy vs. IMRT for newly diagnosed GBM: secondary analysis comparison of progression free survival between clinical radiological assessment vs. response assessment in neuro-oncology (RANO)","volume":"105","author":"Feghali","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.06.009_bib0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","article-title":"Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs. photons","volume":"23","author":"Mohan","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2021.06.009_bib0105","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.2018.77.7078","article-title":"Randomized trials of proton therapy: why they are at risk, proposed solutions, and implications for evaluating advanced technologies to diagnose and treat cancer","volume":"36","author":"Bekelman","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:19Z","timestamp":1761136459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1278321821001074"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.06.009","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nouvelles indications de protonth\u00e9rapie et essais cliniques en cours\u00a0: tumeurs intracr\u00e2niennes","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}